Live
On Demand
Best of SIR 2013: PAD
Learning Objectives
After participating in this activity, learners should be able to:
Describe recent developments in the area of critical limb ischemia and below-knee interventions
Describe methods for predicting and securing successful clinical outcomes from revascularization in patients with lower extremity arterial occlusive disease
Describe the role of new direct drug delivery platforms in CLI
Identify advanced technical strategies for successful trans-catheter revascularization
Speakers
The Time is Now
Robert A. Lookstein, M.D., FSIR, Mount Sinai Hospital, New York, N.Y.
Predicting Outcomes in CLI Revascularization
Irene Bargellini, M.D., University of Pisa, Italy
Pedal Loop, SAFARI, and Other Advanced Techniques
Marco G. Manzi, M.D., Policlinico Abano Terme, Italy
Drugs: Mechanism of Action, FDA Approved Platforms, Future Horizons
Mahmood K. Razavi, M.D., FSIR, St. Joseph Vascular Institute, Irvine, Calif.
Forecast for the future: Corporate market analysis
Tammy Leitsinger, Cordis Corporation, Lebanon, Ohio
Best of SIR 2013: PAD
Learning Objectives
After participating in this activity, learners should be able to:
Describe recent developments in the area of critical limb ischemia and below-knee interventions
Describe methods for predicting and securing successful clinical outcomes from revascularization in patients with lower extremity arterial occlusive disease
Describe the role of new direct drug delivery platforms in CLI
Identify advanced technical strategies for successful trans-catheter revascularization
Speakers
The Time is Now
Robert A. Lookstein, M.D., FSIR, Mount Sinai Hospital, New York, N.Y.
Predicting Outcomes in CLI Revascularization
Irene Bargellini, M.D., University of Pisa, Italy
Pedal Loop, SAFARI, and Other Advanced Techniques
Marco G. Manzi, M.D., Policlinico Abano Terme, Italy
Drugs: Mechanism of Action, FDA Approved Platforms, Future Horizons
Mahmood K. Razavi, M.D., FSIR, St. Joseph Vascular Institute, Irvine, Calif.
Forecast for the future: Corporate market analysis
Tammy Leitsinger, Cordis Corporation, Lebanon, Ohio
test
Renal Denervation: A Primer for Radiologists
Renal denervation is currently in evaluation for various diseases including resistant hypertension, cardiac failure and others. This course will review the pathophysiology, the clinical evidence for renal denervation in resistant hypertension. Most available materials will also be discussed.
Objective
At the end of this session, the learner should be able to: 1.Identify resistant hypertension and describe the role of sympathetic hyperactivity 2.Describe the basics of renal denervation using radiofrequency ablation and other recent technologies 3.Discuss the status of clinical evidence for denervation in resistant hypertension
CME credits for paid registrants = 1.5
Coordinator
Dr. Marc R. Sapoval, MD, PhD, Hopital Europeen Georges Pompidou
Moderator
Dr. Hicham T. Abada, MD, Chandler Hospital
Speaker(s)
Prof. Michel Azizi, MD, PhD, Georges Pompidou European Hospital
Dr. Dagmara Hering,MD, PhD, Baker IDI Heart and Diabetes Institute
Dr. Michael J. Lee, MD, FRCR, FSIR Beaumont Hospital
Dr.Barry T. Katzen, MD, FSIR, Baptist Cardiac & Vascular Institute
Eric Wyffels, Aalst
Panelist(s)
Dr. Mahmood K. Razavi, MD, FSIR, St Joseph Vascular Institute
Dr. Timothy P. Murphy, MD, FSIR, Rhode Island Hospital
Venous Thromboembolic Disease: The Essentials for Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) Management
The VTE categorical course will review the guidelines, protocols and pearls for imaging, treatment and post procedural care in patients with acute and chronic DVT. The PE portion will review the latest guidelines, protocols and clinical pearls for treating submassive and massive acute PE as well as discussing tips for building a VTE practice
Objective
At the end of this session, the learner should be able to: 1.Summarize the latest guidelines for the medical management of patients with DVT and PE 2.Discuss the rationale for treatment as well as current guidelines for interventional therapies in patients with DVT and PE 3.List the treatment options available for patients being evaluated for acute & chronic DVT as well as submassive & massive PE
CME credits for paid registrants = 1.5
Coordinator
Dr. Mark J. Garcia,MD, FSIR, Christiana Care Health Services
Moderator(s)
Dr. William T. Kuo, MD, FSIR, Stanford University Medical Center
Dr. Mark J. Garcia,MD, FSIR, Christiana Care Health Services
Speaker(s)
Shelly Brancatelli, Cleveland Clinic
Dr. Robert A. Lookstein, MD, FSIR, Mount Sinai Hospital
Dr. Mark J. Garcia,MD, FSIR, Christiana Care Health Services
Dr. Suresh Vedantham, MD, FSIR, Mallinckrodt Institute of Radiology
Donald Schreiber, MD,CM, Stanford University School of Medicine
Dr. Akhilesh K. Sista, MD, Weill Cornell Medical College
Dr. Paul Kim, MD, Spectrum Medical Group
Dr. William T. Kuo, MD, FSIR, Stanford University Medical Center
Panelist(s)
Dr. Robert A. Lookstein, MD, FSIR, Mount Sinai Hospital
Dr. Mark J. Garcia,MD, FSIR, Christiana Care Health Services
Dr. Suresh Vedantham, MD, FSIR, Mallinckrodt Institute of Radiology
Dr. William T. Kuo, MD, FSIR, Stanford University Medical Center
Dr. Paul Kim, MD, Spectrum Medical Group
Dr. Akhilesh K. Sista, MD, Weill Cornell Medical College
Donald Schreiber, MD,CM, Stanford University School of Medicine
Advanced Critical Limb Ischemia (CLI) Intervention
This session will focus on new and critical concepts in the care of complex patients with critical limb ischemia. The attendee will learn about advanced technical concepts, as well as strategies for success in caring for patients with advanced lower-extremity atherosclerotic disease.
Objective
At the end of this session, the learner should be able to: 1.Describe methods for predicting and securing successful clinical outcomes from revascularization in patients with lower extremity arterial occlusive disease 2.Describe the role of new direct drug delivery platforms in CLI 3.Identify advanced technical strategies for successful trans-catheter revascularization
CME credits for paid registrants = 1.5
Coordinator
Dr. Laura Findeiss, MD, FSIR, University of California at Irvine School of Medicine
Moderator
Dr. Bret N. Wiechmann, MD, FSIR, Vascular & Interventional Physicians
Speaker(s)
Dr. Laura Findeiss, MD, FSIR, University of California at Irvine School of Medicine
Dr. Bret N. Wiechmann, MD, FSIR, Vascular & Interventional Physicians
Irene Bargellini, University of Pisa
Dr. John H. Rundback, MD, Advanced Interventional Radiology Services, LLP
Dr. Marco Manzi, Policlinico Abano Terme
Dr. Mahmood K. Razavi, MD, FSIR, St Joseph Vascular Institute
Dr. Robert A. Hieb, MD, FSIR, Medical College of Wisconsin
Panelist(s)
Irene Bargellini, University of Pisa
Dr. John H. Rundback, MD, Advanced Interventional Radiology Services, LLP
Dr. Marco Manzi, Policlinico Abano Terme
Backstage Access: Dialysis Interventions 2013
This course will concentrate on the status of hemodialysis access interventions in the Fistula First era. We will focus on what IR clinicians can offer to contribute to the Fistula First effort, as well as to the growing movement to reduce catheter use to the absolute minimum necessary. We will focus on evidence basis including the present controversy concerning prophylactic PTA, the limited role of stents and stent grafts, and related topics.
Objective
At the end of this session, the learner should be able to: 1.Describe the Fistula First initiative and the related 'catheter last' movement 2.List three ways in which IR clinicians directly contribute to the Fistula First initiative 3.Explain the evidentiary basis for a preference of stent grafts over stents, in the uncommon situations these devices are indicated 4.Describe the difference in outcomes of IR interventions expected for fistulae and grafts
CME credits for paid registrants = 1.5
Coordinator
Dr. Scott O. Trerotola, MD, FSIR, University of Pennsylvania Medical Center
Moderator
Dr. Gordon McLennan,MD, FSIR, Cleveland Clinic
Speaker(s)
Dr. Michael Allon, University of Alabama Birmingham
Dr. Thomas M. Vesely, MD, FSIR, Vascular Access Services, LLC
Dr. Timothy W.I. Clark, MD, FSIR, Penn Presbyterian Medical Center
Dr. Bart L. Dolmatch, MD, FSIR, Palo Alto Medical Foundation
Dr. Karim Valji, MD, FSIR, University of Washington
Best of SIR 2013: Interventional Oncology
Program Description
This live online event is a rebroadcast of the popular session, Management of Patients with Hepatocellular Carcinoma, from the SIR 2013 Annual Scientific Meeting. Faculty will be online during the broadcast to interact with attendees and answer questions.The presentation explains the epidemiology of hepatocellular carcinoma (HCC), and the meaning of systemic targeted agents and molecular biomarkers. Experts in the treatment of HCC review the various stages and available treatments of HCC, as well as the risks of and outcomes following those treatments.
Learning Objectives
After participating in this activity, learners should be able to:
1.Describe the epidemiology of hepatocellular carcinoma (HCC)
2.Explain the meaning of systemic targeted agents and molecular biomarkers
3.Summarize the various stages of HCC and the indications for all available treatments
4.Identify the benefits and potential risk of the various treatments for HCC
CME Credit
The Society of Interventional Radiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Society of Interventional Radiology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Talk Titles
Distinguished Abstract: Transcatheter intraarterial delivery of superparamagentic iron oxide-labeled natural killer lymphocytes to hepatocellular carcinoma: longitudinal efficacy studies in a rat model, Alexander Sheu
Epidemiology and Staging of HCC, Ghassan Abou-Alfa, MD and David Cosgrove, MD
Targeted Agents: Sorafenib and beyond, David Cosgrove, MD
Importance of Biomarkers and Tailoring Therapy, David Cosgrove, MD
Early HCC, Robert Lewandowski, MD, FSIR
Management of Intermediate-Advanced HCC, Jeff Geschwind, MD, FSIR
Speaker(s)
Ghassan Abou-Alfa, MD, Memorial Sloan-Kettering Cancer Center, New York, N.Y.
David Cosgrove, MD,Johns Hopkins University, Baltimore, Md.
Robert Lewandowski, MD, FSIR, Northwestern Memorial Hospital, Chicago, Ill.
Jeff Geschwind, MD, FSIR, Interventional Radiology Center- The Johns Hopkins Hospital, Baltimore, Md.
Alexander Sheu, Northwestern University - Feinberg School of Medicine, Chicago Ill.
Best of SIR 2013: Venous Interventions
Program Description
This live online event will rebroadcast selected venous disease focused presentations from the SIR 2013 Annual Scientific Meeting. Faculty will be online during the broadcast to interact with attendees and answer questions. The rebroadcast will review the guidelines, protocols and pearls for imaging, treatment and post procedural care in patients with acute and chronic DVT. The PE portion will review the latest guidelines, protocols and clinical pearls for treating submassive and massive acute PE.
Learning Objectives
After participating in this activity, learners should be able to:
1.Summarize the latest guidelines for the medical management of patients with DVT and PE
2.Discuss the rationale for treatment as well as current guidelines for interventional therapies in patients with DVT and PE
3.List the treatment options available for patients being evaluated for acute & chronic DVT as well as submassive & massive PE
CME Credit
The Society of Interventional Radiology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. The Society of Interventional Radiology designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Speaker(s)
Common Femoral Vein waveform analysis – Neil M. Khilnani, MD, Cornell Vascular, New York, NY
Deciding on which lytic tool & what tricks to use – Robert A. Lookstein, MD, FSIR, Mount Sinai Hospital, New York, NY
Changing the landscape of DVT and PTS – Mark J. Garcia, MD, FSIR, University of New Mexico, Albuquerque, NM
Algorithm of CDT for Massive PE – William T. Kuo, MD, Stanford University Medical Center, Palo Alto, CA
Post procedure management for venous disease – Suresh Vedantham, MD, FSIR, Mallinckrodt Institute of Radiology, Saint Louis, MO
Conversion
Conversion 11.14
Extreme IR
Come to Extreme IR for ingenuity, innovation...and stress. See rapid-fire presentations and discussions of innovative IR and endovascular cases, solutions, and diagnostic and therapeutic dilemmas. Witness what presenters have done when faced with the need for something that has not been seen nor done before, for which the right tools may not exist. This is the extreme IR zone.
Objective
At the end of this session, the learner should be able to: 1.Describe novel and complex embolizations in vascular and nonvascular applications 2.Review the use of innovative tools in arterial and venous obstruction and bleeding 3.Analyze the use of implantable devices, such as stents and stent grafts in atypical and/or emergent scenarios
CME credits for paid registrants = 1.5
Coordinator
Prof. Ziv J. Haskal, MD, FSIR, University of Maryland
Moderator
Dr. Michael D. Dake, MD, Falk Cardiovascular Research Center
Speaker(s)
Dr. Bart L. Dolmatch,MD, FSIR, Palo Alto Medical Foundation
Dr. Riad Salem, MD, MBA, FSIR, Northwestern Memorial Hospital
Dr. John F. Angle, MD, University of Virginia Health System
Dr. Matthew S. Johnson, MD, FSIR, Indiana University School of Medicine
Dr. Mahmood K. Razavi, MD, FSIR, St Joseph Vascular Institute
Dr. Stephen T. Kee, MD, FSIR, Ronald Reagan UCLA Medical Center
Prof. Ziv J. Haskal, MD, FSIR, University of Maryland
Dr. Michael D. Dake, MD, Falk Cardiovascular Research Center
Dr. James F. Benenati, MD, FSIR Baptist Cardiac & Vascular Institute
Professor Johannes Lammer, MD, University Clinics Vienna
Professor Kimihiko Kichikawa, MD, Nara Medical University
Dr. L. Nelson Hopkins, MD, Jacobs Institute/UB Neurosurgery, Inc.
Dr. Shaun L. Samuels, MD, FSIR, Baptist Cardiac and Vasc. Institute
Imaging Guidance/Targeting and Emerging Therapies for Cancer
Objective
At the end of this session, the learner should be able to: 1.Describe the role of cone beam CT imaging during intra-arterial therapy for liver cancer 2.Explain the role of molecular imaging to guide local treatment for cancer 3.Summarize the various imaging response criteria and identify the pros and cons of each 4.Discuss the new ablative techniques and intra-arterial therapies
CME credits for paid registrants = 1.5
Coordinator
Dr. Jeff H. Geschwind, MD, FSIR, Interventional Radiology Center- The Johns Hopkins Hospital
Moderator(s)
Professor Riccardo A. Lencioni,MD, FSIR, EBIR, University of Pisa
Dr. Kamran Ahrar, MD, MD Anderson Cancer Center
Speaker(s)
Mikhail Silk, Memorial Sloan-Kettering Cancer Center
Dr. MingDe Lin, Philips Research North America
Dr. Bradford Johns Wood, MD, National Institutes of Health, National Cancer Institute
Dr. Stephen B. Solomon, MD, FSIR, Memorial Sloan Kettering Cancer Center
Dr. Riad Salem, MD, MBA, FSIR, Northwestern Memorial Hospital
Professor Riccardo A. Lencioni,MD, FSIR, EBIR, University of Pisa
Dr. Jeff H. Geschwind, MD, FSIR, Interventional Radiology Center- The Johns Hopkins Hospital
Reproductive Embolotherapy
This categorical course will focus on embolization procedures in the male and female pelvis. This will include an update on prostate embolization and the fundamentals of practice development in this area. It will also include updates on varicocele embolization, embolization for pelvic congestion syndrome and uterine fibroid embolization, with particular attention on current and future embolic agents and management of complications.
Objective
At the end of the session the learner should be able to: 1. Describe the anatomy of the prostate gland and the technique of prostate embolization 2. Identify strategies for developing a prostate embolization practice 3. Explain how to diagnose and treat pelvic congestion syndrome and scrotal varicocele 4. Review current and future embolic agents for uterine artery embolization 5. Summarize the recent advances in UAE for fibroid disease 6. Manage complications of uterine artery embolization for fibroids
CME credits for paid registrants = 1.5
Coordinator
Dr. Gary P. Siskin, MD, FSIR, Albany Medical College
Moderator(s)
Dr. Richard Shlansky-Goldberg, MD, FSIR, University of Penn. Med Ctr.
Dr. Gary P. Siskin, MD, FSIR, Albany Medical College
Speaker(s)
Prof. Francisco Cesar Carnevale, MD., PhD., University of Sao Paulo Medical School
Dr. Gary P. Siskin, MD, FSIR, Albany Medical College
Dr. Lindsay Machan, MD, FSIR, University of British Columbia Hospital
Dr. Anthony C. Venbrux, MD, FSIR, George Washington Univ Med Ctr
Dr. James B. Spies, MD, MPH, FSIR, Georgetown University Medical Center
Professor Jean-Pierre Pelage,MD, PhD, Department of Radiology CHU de Caen
Dr. Richard Shlansky-Goldberg, MD, FSIR, University of Penn. Med Ctr.
Dr. Tiago A. Bilhim, MD, PhD, Saint Louis Hospital
test
Test
Tumor Board on HCC and Colorectal Liver Metastases
This course will concentrate on the status of hemodialysis access interventions in the Fistula First era. We will focus on what IR clinicians can offer to contribute to the Fistula First effort, as well as to the growing movement to reduce catheter use to the absolute minimum necessary. We will focus on evidence basis including the present controversy concerning prophylactic PTA, the limited role of stents and stent grafts, and related topics.
Objective
At the end of this session, the learner should be able to: 1.Describe the Fistula First initiative and the related 'catheter last' movement 2.List three ways in which IR clinicians directly contribute to the Fistula First initiative 3.Explain the evidentiary basis for a preference of stent grafts over stents, in the uncommon situations these devices are indicated 4.Describe the difference in outcomes of IR interventions expected for fistulae and grafts
CME credits for paid registrants = 1.5
Coordinator
Dr. Scott O. Trerotola, MD, FSIR, University of Pennsylvania Medical Center
Moderator
Dr. Gordon McLennan,MD, FSIR, Cleveland Clinic
Speaker(s)
Dr. Michael Allon, University of Alabama Birmingham
Dr. Thomas M. Vesely, MD, FSIR, Vascular Access Services, LLC
Dr. Timothy W.I. Clark, MD, FSIR, Penn Presbyterian Medical Center
Dr. Bart L. Dolmatch, MD, FSIR, Palo Alto Medical Foundation
Dr. Karim Valji, MD, FSIR, University of Washington
April 14th
April 15th
April 16th
April 17th
November 14th
October 24th
On Demand
Cook Medical
Host Space [1082]
Sirtex
Badge Leaderboard
Boston Scientific
Boston Scientific (NYSE: BSX) is a worldwide developer, manufacturer and marketer of medical devices with approximately 24,000 employees and revenue of $7.622 billion in 2011. For more than 30 years, Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties. The Company’s products help physicians and other medical professionals improve their patients’ quality of life by providing alternatives to surgery. For more information, please visit www.bostonscientific.com.
Boston Scientific, medical device, peripheral interventions, interventional cardiology, interventional radiology, endoscopy, radio frequency ablation, stent, renal denervation, balloon dilatation catheter, catheter, CTO, guidewire, support catheter, controlwire, detachable coil, Renegade, Interlock, Vessix, TruePath, Rubicon, WallFlex, Mustang, Coyote, V-14
Cook Medical
Cook
We believe there are no limits to what you can do—whether you’re fighting cancer, treating aortic disease, or combating PAD. That’s why for 50 years, Cook Medical has offered more than just proven interventional products. With Cook Medical, you can also:
- Share best practices with physicians worldwide.
- Rely on our experienced team of specialists.
- Expand your interventional skill set.
- Partner with a leader in patient-focused, physician-driven innovation.
Cook, Cook Medical, Zilver, Zenith, Celect, PAD, Gastroenterology, Drainage, Percutaneous Drainage, Medical Device, Aprima, Ratchet, Retracta, Interventional Radiology, Peripheral Intervention, Aortic Intervention, AAA
Demo 2
Demo
INXPO puts on virtual events.....
Demo, INXPO,
Help Desk
Help Desk - Eclipse
Help Desk
Interactive Theater
Theater - Genesis
Interactive Theater
Landind Page
Universal Space
Landind Page
Networking Lounge
Whos Here
Networking Lounge
Resource Center - Eclipse
Sirtex Medical, Inc.
Sirtex
Sirtex Medical, Inc., headquartered in Australia and with U.S. operations in Woburn, Mass., is a global life-sciences company that develops and delivers effective oncology treatments using novel small particle technology. Sirtex is committed to developing new procedures for the treatment of cancer while expanding the availability of Selective Internal Radiation Therapy (SIRT) to those in need. Sirtex manufactures SIR-Spheres® microspheres, microscopic polymer beads that contain the radioactive isotope Y-90 and emit beta radiation to kill cancer cells. SIR-Spheres microspheres are FDA approved for the treatment of unresectable colorectal liver metastases. Clinical studies have shown SIRT with SIR-Spheres microspheres increases the time-to-disease progression and overall survival without adversely affecting the patient’s quality of life.
Sirtex, SIR-Spheres microspheres, colorectal cancer, radioembolization, liver tumors, Y-90, interventional radiology
Sponsor Directory
Universal Space
Sponsor Directory
Sponsors
Sponsor Directory - Genesis (2)
Sponsors
St. Jude Medical
St. Jude
St. Jude Medical develops medical technology and services that focus on putting more control into the hands of those who treat cardiac, neurological and chronic pain patients worldwide. The company is dedicated to advancing the practice of medicine by reducing risk wherever possible and contributing to successful outcomes for every patient. St. Jude Medical is headquartered in St. Paul, Minnesota and has four major focus areas that include: cardiac rhythm management, atrial fibrillation, cardiovascular and neuromodulation.
St. Jude, plugs, coils, IR, Interactive Session, SJM, AVP, AS, Angio-Seal, angioseal, evolution, VIP, medical device, interventional, aneurysm, case study, whitepaper, resources, booth, closure, device,
Access for Transluminal Billiary Biopsy and Percutaneous Drainage Visual Guide
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
3
Aprima Access Nonvascular Introducer Set Product Information Sheet
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
5
Bone Biopsy and Infusion Products
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
5
Brochure - AMPLATZER Family of Plugs AMPLATZER Family of Plugs
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Brochure - Angio-Seal Evolution Angio-Seal Evolution
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Brochure - Angio-Seal VIP Angio-Seal VIP
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Cantata Superselective Microcatheter
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
5
Carotid Wallstent Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Case Study - Antegrade Approach - Angio-Seal Antegrade Approach
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - AVFistula - AVP4 AVFistula
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - Embolisation - Angio-Seal Embolisation - Angio-Seal
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - GDA - Angio-Seal GDA
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - PAVM - AVP4 PAVM
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - Recanalization - Angio-Seal Recanalization
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - Renal - AVP4 Renal
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - SpermaticVein - AVP4 SpermaticVein
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - SplenicArtery - AVP4 SplenicArtery
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - Staged Approach - Angio-Seal Staged Approach
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study - VCD Lower Limb - Angio-Seal VCD Lower Limb
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Case Study (Amor) Angio-Seal Usage of the Angio-Seal™ Vascular Closure Device
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
3
Chait Percutaneous Cecostomy Catheter
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
5
Cope Gastrojejunostomy Cannula
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
Coyote Catheter Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Downstaging Unresectable Liver Tumors Through Selective Internal Radiation Therapy Using SIR-Spheres® microspheres
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Embolic Therapies
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Enterocutaneous Fistula Plug
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Epic Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Express LD Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Express SD Renal Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
IFU - AngioSealEvolution
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
IFU - AngioSealVIP
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
IFU - AVP1
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
IFU - AVP2
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
IFU - AVP4
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Improving Outcomes: Exploring the Benefits of SIRT Using Y-90 Resin Microspheres in Patients with Metastatic Colorectal Cancer
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Interlock Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Interventional Gastroenterology
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Interventional Radiology Overview
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Link
Http://inxpo.com
0
Liver Access and Biopsy Sets
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
MReye Embolization Coil
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Mustang Catheter Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Nester Embolization Coil
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
Osteo-Site Biopsy Needle Sets
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Percutaneous Drainage Products
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Peripherally Inserted Central Venous Catheters
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
PVA Particles
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
Renegade Microcatheter Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Retracta Detachable Embolization Coil
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
5
Roberts Slip-Cath
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
Rubicon Family Sell Sheet
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
SIR-Spheres Advertisement The only Y-90 microspheres achieving optimal tumor coverage
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
SIR-Spheres Advertisement The only Y-90 microspheres allowing visualized delivery confirmation
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
SIR-Spheres Advertisement The only Y-90 microspheres with RCT data and full FDA approval
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
SIR-Spheres microspheres Product Sheet
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Test PDF
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Tornado Embolization Coil
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
Transluminal Biliary Biopsy Forceps Set
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
Transluminal Biliary Biopsy Forceps Visual Guide
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
TruePath Brochure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
UFE Procedure
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
3
Vascular Retrieval Forceps
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
Victory Guidewire Sell Sheet
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
2
Video - Peripheral Embolization - AVP4
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Video Angio-Seal Evolution Components and Demonstration Product and Demonstration
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
White Lumax Guiding Catheter
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
White paper - Angio-Seal
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
0
Wire Guides
https://content.onlinexperiences.com/cfr/ContentRemoved.htm
1
test test
https:///inxpo.com
0
Attendee Package Free
This Package provides access to the entire event
Attendee Package Paid
Clinical and Practice Development
Embolization
Gastrointestinal Interventions
Musculoskeletal
Neurovascular and Carotid Interventions
Nonvascular Interventions
Oncologic Interventions
Pediatric Interventions
Peripheral Arterial Interventions
Venous Interventions
Women's Health